Health News Stories

Excerpts of Key Health News Stories in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

[A] study finds sperm levels of men who kept their phones in their pocket during the day were quite seriously affected in 47 per cent of cases. Fertility experts are warning men that using a mobile for as little as an hour a day is "cooking sperm". The new study shows that having a mobile phone close to the testicles - or within a foot or two of the body - can lower sperm levels so much that conceiving could be difficult. Professor Martha Dirnfeld, of the Technion University in Haifa, said: "We analysed the amount of active swimming sperm and the quality and found that it had been reduced. We think this is being caused by a heating of the sperm from the phone and by electromagnetic activity." The team monitored more than 100 men attending a fertility clinic for a year. They found that besides men keeping their phones close to their groin many spoke on the phone while it was charging and kept it only a few centimetres from their bed. Even keeping the phone on a bedside table appears to raise lower sperm cell counts. The findings are in the journal Reproductive BioMedicine and support a long-feared link between dropping fertility rates in men and the prevalent use of cellular phones. The quality of sperm among men in Western countries is constantly decreasing and is considered crucial in 40 percent of the cases in which couples have difficulty conceiving a child.

Note: This Newsweek article states that Apple advises not to keep your cell phone in your pocket. For lots more reliable information on cellphone risk, read this well researched article. And watch an excellent, informative video interview with Dr. Nick Begich on the dangers of cell phone radiation. For more along these lines, see concise summaries of deeply revealing news articles on mobile phones from reliable major media sources.

Naloxone works by blocking the effect that painkillers and heroin have in the brain and reversing the slowed breathing and unconsciousness that come with an overdose. But as the demand for naloxone has risen - overdose deaths now total 130 every day, or roughly the capacity of a Boeing 737 - the drug’s price has soared. Not long ago, a dose of the decades-old generic drug cost little more than a dollar. Now the lowest available price is nearly 20 times that. In 2014, more than 47,000 Americans died from drug overdoses. That was 50% more deaths than from highway accidents ... and more overdose deaths than any year on record. The overdose crisis has its roots in the 1990s, when doctors began prescribing more and higher doses of painkillers [in response] to campaigns, often funded behind the scenes by drug makers, that urged doctors to prescribe the strongest painkillers not just to cancer patients and others in severe pain, but also to those with milder pain. The narcotic manufacturers’ funding of those campaigns ... came to light through evidence unearthed in lawsuits and investigative journalism reports. Since 1999, the amount of prescription opioids such as oxycodone, morphine and hydrocodone sold in the U.S. nearly quadrupled. During that same time, deaths from those drugs quadrupled. The lethal side effects of that booming prescription painkiller market has now sparked a moneymaking opportunity with naloxone.

Note: Tens of thousands of deaths are caused by prescription opioid overdose in the US each year. If Big Pharma sees this as an opportunity to profit, what does that say about the healthcare system?

Painkiller abuse and overdose are lower in states with medical marijuana laws. When medical marijuana is available, pain patients are increasingly choosing pot over powerful and deadly prescription narcotics. Now a new study [provides] clear evidence of a missing link in the causal chain running from medical marijuana to falling overdoses. Researchers at the University of Georgia scoured the database of all prescription drugs paid for under Medicare Part D from 2010 to 2013. In the 17 states with a medical-marijuana law in place by 2013, prescriptions for painkillers and other classes of drugs fell sharply compared with states that did not have a medical-marijuana law. They found that, in medical-marijuana states, the average doctor prescribed 265 fewer doses of antidepressants each year, 486 fewer doses of seizure medication, 541 fewer anti-nausea doses and 562 fewer doses of anti-anxiety medication. But most strikingly, the typical physician in a medical-marijuana state prescribed 1,826 fewer doses of painkillers in a given year. Estimating the cost savings to Medicare from the decreased prescribing, [the study] found that about $165 million was saved in the 17 medical marijuana states in 2013. The estimated annual Medicare prescription savings would be nearly half a billion dollars if all 50 states were to implement similar programs.

Note: The war on drugs has been called a "trillion dollar failure", and an increasing number of deaths are caused by prescription opioid overdose in the US each year. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

On May 18, a team working at the Walter Reed Army Institute of Research here had its first look at a sample of the bacterium Escherichia coli, taken from a 49-year-old woman in Pennsylvania. Her sample was one of six from across the country delivered to the lab of microbiologist Patrick McGann. Within hours, a preliminary analysis deepened concern at the lab. Over the next several days, more sophisticated genetic sleuthing confirmed McGann’s worst fears. There, in the bacterium’s DNA, was a gene [that] made the pathogen impervious to the venerable antibiotic colistin. More ominously, the gene’s presence ... suggested that it could readily jump to other E. coli bacteria, or to entirely different forms of disease-causing organisms. That would make them impervious to colistin as well. It was a milestone public health officials have been anticipating for years. In a steady march, disease-causing microbes have evolved ways to evade the bulwark of medications used to treat bacterial infections. For a variety of those illnesses, only colistin continued to work every time. Now this last line of defense had been breached as well. Almost as soon as they were given to patients, scientists began finding evidence that disease-causing bacteria were developing resistance to these new wonder drugs. Humans have accelerated this natural process by indiscriminately prescribing antibiotics and by routinely feeding the drugs to livestock.

Note: Millions of unnecessary drug prescriptions and rampant overuse of antibiotics in livestock also produces autoimmune diseases that were virtually unknown to our ancestors. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Vaccination prices have gone from single digits to sometimes triple digits in the last two decades, creating dilemmas for doctors and their patients as well as straining public health budgets. Some doctors have stopped offering immunizations because they say they cannot afford to buy these potentially lifesaving preventive treatments that insurers often reimburse poorly, sometimes even at a loss. Childhood immunizations are so vital to public health that the Affordable Care Act mandates their coverage at no out-of-pocket cost and they are generally required for school entry. Old vaccines have been reformulated with higher costs. New ones have entered the market at once-unthinkable prices. Together, since 1986, they have pushed up the average cost to fully vaccinate a child with private insurance to the age of 18 to $2,192 from $100, according to data from the Centers for Disease Control and Prevention. The costs for the federal government, which buys half of all vaccines for the nation’s children, have increased 15-fold during that period. The most expensive shot for young children ... is Prevnar 13, which prevents diseases caused by pneumococcal bacteria, from ear infections to pneumonia. Each shot is priced at $136, and most states require children to get four doses before entering day care or preschool. Pfizer, the sole manufacturer, had revenues of nearly $4 billion from its Prevnar vaccine line last year.

Note: Read an excellent article on how big Pharma is raking in the big bucks on vaccines which haven't even been adequately tested for safety. For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and vaccine controversies from reliable major media sources.

Thousands of dogs across Britain are dying or suffering severe allergic reactions after being treated with a vaccine meant to protect them against mild bacterial infections. Fears over the safety of the vaccine against leptospirosis - a bacterial infection spread to dogs through rats and wild animals – have now led veterinary organisations to issue warnings about its side effects. The World Small Animal Veterinary Association (WSAVA) is urging owners not to use Nobivac L4 vaccine on puppies under 12 weeks old. However, [it] is still being administered in veterinary practices across Britain to dogs from seven weeks old, with little warning of the potential side effects. According to reports made to the Government's Veterinary Medicines Directorate (VMD) by pet owners, more than 120 dogs are feared to have died after receiving a dosage in the three years the product has been on the market. In the last two years, regulators have received 2,000 reports of dogs having suspected adverse or fatal reactions. Owners that have opted for the L4 vaccine ... have reported adverse effects including epileptic fits, swollen glands and blindness. The vaccine, which is manufactured by MSD Animal Health, a subsidiary of American conglomerate Merck Sharp & Dohme, is currently being monitored by the VMD. The regulator has however refused to reveal the total number of animals that had been affected since the product came onto the market, prompting concern among dog owners that the scale of problem is being kept hidden from the public.

Note: For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

It's the time of year when experts crunch the numbers to see how well the flu shot worked. The result? Better than last year, but still not good enough. "Just shy of 45 to 50 per cent," said Dr. Danuta Skowronski of the BC Centre for Disease Control, who presented the data to the Global Influenza Vaccine Effectiveness meeting at the World Health Organization last week. In 2014-15, the flu shot offered essentially zero protection against the circulating influenza virus of that season. Back then, the prevailing strain was H3N2. This year's main circulating virus was H1N1. Skowronski said the vaccine was ... disappointing. Experts used to believe the annual flu shot protection was much higher, around 70 to 90 per cent. But not anymore. Those early estimates were based on industry-funded clinical trials that were extrapolated to apply across all ages and flu seasons. "It was a blanket assumption that is simply not true," Skowronski said. That assumption changed dramatically, after Skowronski and colleagues developed a protocol that revealed the true picture of vaccine efficacy. It's called the test negative design (TND) first piloted in Canada in 2004. "The test negative design has opened our eyes to all kinds of variables that we were blind to for years," said Skowronski. Scientists also once again observed [that] people who get the shot with no prior vaccine exposure seem to have better protection than people who get the shot year after year.

Note: A National Institute of Health study found in 2007 that flu shots do not protect the elderly. More recent studies have shown that some flu shots actually increase the risk of infection. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

As the Internet lights up with images of the iPhone 6 plus emerging from people’s pockets bent like a used paperclip, it may be useful to consider this: Apple explicitly tells you not to carry your phone in your pocket, due to the radiation exposure threat it poses. In the little handbook that comes with every iPhone ... Apple also explicitly states that the phone is not supposed to touch your body much, if at all. The iPhone 3G safety manual warns that radiation exposure may exceed government standards during “body-worn operation” if the phone is “positioned less than 15 millimeters (5/8 inch) from the body (e.g., when carrying iPhone in your pocket).” The iPhone, Apple says, should always be worn in a belt clip or holster. Cell phone radiation, measured in radio-frequency exposure, is regulated in the U.S. by the Federal Communications Commission (FCC). All phones must be tested to ensure that they emit a specific absorption rate of not more than 1.6 watts of radio-frequency energy per kilogram of body tissue, a rule designed to prevent harm from the heat generated by radio-frequency waves. There are ... gaps in cell phone radiation testing. The American Academy of Pediatrics, for example, recently urged the FCC to begin taking child users of cellphones into account. Radiation from cell phones is not an Apple-only problem, of course. Blackberry’s user manual advises .59 inches of separation between the body and the phone. Earlier manuals pushed for nearly a full inch (.98 inch) of separation.

Note: Industry-funded safety studies have been found to downplay cellphone risks, while regulators like the Centers for Disease Control and Prevention provide unclear guidance on these risks. For lots more reliable information on cellphone risk, read this well researched article. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Something strange is going on in medicine. Major diseases, like colon cancer, dementia and heart disease, are waning in wealthy countries, and improved diagnosis and treatment cannot fully explain it. Scientists marvel at this good news, a medical mystery of the best sort. The leading killers are still the leading killers - cancer, heart disease, stroke - but they are occurring later in life, and people in general are living longer in good health. Colon cancer is the latest conundrum. While the overall cancer death rate has been declining since the early 1990s, the plunge in colon cancer deaths is especially perplexing: The rate has fallen by nearly 50 percent since its peak in the 1980s. [Dr. Steven R. Cummings of the California Pacific Medical Center Research Institute], intrigued by the waning of disease, has a provocative idea for further investigation. He starts with two observations: Rates of disease after disease are dropping. Even the rate of “all-cause mortality,” which lumps together chronic diseases, is falling. And every one of those diseases at issue is linked to aging. Perhaps, he said, all these degenerative diseases share something in common, something inside aging cells themselves. The cellular process of aging may be changing, in humans’ favor. For too long, he said, researchers have looked under the lamppost at things they can measure. “I want to look inside cells,” Dr. Cummings said. Inside, there could be more clues to this happy mystery.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Nearly all food labels in Vermont are now required to disclose when products include genetically engineered ingredients. The requirement, passed two years ago, became effective on Friday. The rule is the first of its kind in the United States, and although it applies only within the tiny state, it is having national impact. Most major food and beverage companies have already added language to their labels to meet the new rule, rather than deal with the logistical hassle of having separate labels for different states. But not all the same products will definitely be on shelves. Vermont’s law requires the labeling of most packaged grocery products as well as any whole fruits or vegetables produced with genetic engineering. That means virtually all products containing derivatives of crops like corn, soy, canola and sugar from sugar beets will need labels, as most of those crops in the United States are grown from genetically modified seeds. Vermont’s law is careful, however, to exclude cheese, a big business in the state. The law also exempts meat from animals that have eaten feed made from genetically engineered grains. The labeling issue has generated heavy and frantic lobbying by the Grocery Manufacturers Association and the trade groups representing major commodity producers of crops like soy and corn, who have wanted a federal law that would prevent mandatory labels.

Note: On July 8, the US Senate passed a bill which allows food companies to continue to avoid clear GMO ingredient labeling. Let's hope it does not pass the full Congress and become a law. For more along these lines, see concise summaries of deeply revealing food industry corruption and GMO news articles from reliable major media sources.

Treating the hepatitis C virus used to require frequent injections and daily pills that had to be taken for up to a year with flu-like side-effects. Tolerable drugs that could eliminate the infection in most patients in about 12 weeks were introduced in 2013. But the retail price for an eight- to 24-week regimen of the anti-virals ranged from $55,000 to $80,000 in 2015. Now the non-profit organization Drugs for Neglected Diseases Initiative and Egyptian drug maker Pharco Pharmaceuticals have signed agreements to provide a combination of the Hepatitis C drugs sofosbuvir and the antiviral ravisdasvir for further clinical tests for $300 US or less per treatment course. The agreement was announced this week at the International Liver Congress ... said Dr. Isabelle Andrieux-Meyer, HIV and hepatitis C medical advisor for Doctors Without Borders. The drugs make such a difference in wealthy countries but the contrast in lower and middle income countries is "brutal," Andrieux-Meyer said. "So many patients can't buy treatment," she said. Under the agreement, the company agreed to set the commercial price at $294 US or less per treatment course once the scale-up is approved. Doctors Without Borders is a member of the Drugs for Neglected Diseases Initiative, which has licensed rights for ravisdasvir in low- and middle-income countries from Presidio Pharmaceuticals.

Note: While it is great that these medications may become more affordable in low-income countries, hepatitis C drugs are priced and marketed to maximize revenue regardless of the human consequences. For more along these lines, see concise summaries of deeply revealing Big Pharma profiteering news articles from reliable major media sources.

As a physician, I have encountered many people who believe that heart disease, which is the single biggest cause of death among Americans, is largely controllable. After all, if people ate better, were physically active and stopped smoking, then lots of them would get better. This ignores the fact that people can’t change many risk factors of heart disease like age, race and family genetics. People don’t often seem to feel the same way about cancer. They think it’s out of their control. A ... recent study published in Nature argues that there is a lot we can do. Many studies have shown that environmental risk factors and exposures contribute greatly to many cancers. Diet is related to colorectal cancer. Alcohol and tobacco are related to esophageal cancer. HPV is related to cervical cancer, and hepatitis C is related to liver cancer. And you’d have to be living under a rock not to know that smoking causes lung cancer and that too much sun can lead to skin cancer. Using sophisticated modeling techniques, the researchers argued that less than 30 percent of the lifetime risk of getting many common cancers was because of intrinsic risk factors, or the “bad luck.” The rest were things you can change. [More] recently, in JAMA Oncology, researchers sought to quantify how a healthful lifestyle might actually alter the risk of cancer. They [found that] about 25 percent of cancer in women and 33 percent in men was potentially preventable.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Federal scientists released partial findings Friday from a $25-million animal study that tested the possibility of links between cancer and chronic exposure to the type of radiation emitted from cell phones and wireless devices. The findings, which chronicle an unprecedented number of rodents subjected to a lifetime of electromagnetic radiation starting in utero, present some of the strongest evidence to date that such exposure is associated with the formation of rare cancers in at least two cell types in the brains and hearts of rats. The results, which were posted on a prepublication Web site run by Cold Spring Harbor Laboratory, are poised to reignite controversy about how such everyday exposure might affect human health. Researchers at the National Toxicology Program (NTP), a federal interagency group under the National Institutes of Health, led the study. They chronically exposed rodents to carefully calibrated radio-frequency (RF) radiation levels designed to roughly emulate what humans with heavy cell phone use or exposure could theoretically experience in their daily lives. The animals were placed in specially built chambers that dosed their whole bodies with varying amounts and types of this radiation for approximately nine hours per day throughout their two-year life spans. “This is by far—far and away—the most carefully done cell phone bioassay, a biological assessment,” says Christopher Portier ... who helped launch the study

Note: For lots more reliable information on cellphone risk, read this well researched article. And this excellent article reveals the serious dangers of 5G wireless technology which is being rolled out. Watch an excellent, informative video interview with Dr. Nick Begich on the dangers of cell phone radiation. In 2012, the American Academy of Pediatrics urged the US to reassess cell phone safety standards for children. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Lisa Alamia had the jaw surgery in December. She underwent the procedure to correct a serious overbite, and it was a success, according to Houston Methodist Sugar Land Hospital. The 33-year-old woke up and had minimal swelling. But then she began to talk. The voice coming out of Alamia’s mouth didn’t sound like it belonged to a Houston-area native. It sounded British. “My daughter laughs at the way I say ‘tamales.’ I used to be able to say it like a real Hispanic girl,” Alamia told KHOU. “Now, I cannot.” Months later, she still speaks as if she’s from across the pond. Eventually, she saw neurologist Toby Yaltho at Houston Methodist Sugar Land Neurology Associates, who diagnosed her with a very rare condition: Foreign Accent Syndrome, or FAS. The rare speech disorder was first described in 1907 by French neurologist Pierre Marie, and since then, there have been only about 100 documented cases. A person with FAS has an accent considered by the patient, others and doctors to sound “foreign” and unlike the patient’s previous dialect. Previous exposure to such an accent isn’t necessary. FAS usually follows stroke, while it’s also been diagnosed following traumatic brain injury, cerebral hemorrhage and multiple sclerosis. Only a few cases seem to have psychological origins. The cause of Alamia’s FAS remains a mystery. “Everything came back normal,” Yaltho said in a release. “There was no evidence of stroke or other abnormalities.”

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Researchers from Brown University made headlines after they successfully demonstrated how a paralyzed woman who had lost the use of her arms and legs could control a robotic arm using her brainwaves. In a video, Cathy Hutchinson imagines drinking a cup of coffee, and the robotic arm brings the cup to her lips. Hutchinson is connected to the robotic arm through a rod-like “pedestal” driven into her skull. Researchers at UC Berkeley has been working on plans for a less invasive, wireless monitoring system. Earlier this month, they released a draft paper: “Neural Dust: An Ultrasonic, Low Power Solution for Chronic Brain-Machine Interfaces.” Dongjin Seo, a [UC Berkeley] graduate student ... authored the paper under the supervision of senior faculty members, including Michel Maharbiz who has famously created cyborg beetles for the US Defense Department. Seo said the researchers’ goal is to build an implantable system that is ultra-miniature, extremely compliant, and scalable to be viable for a lifetime, for brain-machine interfaces. The Berkeley researchers propose to sprinkle the brain with tiny, dust-sized, wireless sensors. This would reduce the risk of infection ... and limit the trauma to one initial operation. During that operation, the skull would be opened, and sensors would be inserted into the brain. At the same time a separate transceiver would be placed directly under the skull but above the brain. The transceiver would communicate with the sensors via ultrasound.

Note: For information on the risks and dangers of this invasive technology being used to control minds, see this article. For more along these lines, see concise summaries of deeply revealing news articles on microchip implants and mind control.

The real time monitoring of brain function has advanced in leaps and bounds in recent years. That’s ... led to a new engineering discipline of brain-machine interfaces, which allows people to control machines by thought alone. Today, Dongjin Seo and pals at the University of California Berkeley reveal an entirely new way to study and interact with the brain. Their idea is to sprinkle electronic sensors the size of dust particles into the cortex and to interrogate them remotely using ultrasound. The ultrasound also powers this so-called neural dust. Each particle of neural dust consists of standard CMOS circuits and sensors that measure the electrical activity in neurons nearby. This is coupled to a piezoelectric material that converts ultra-high-frequency sound waves into electrical signals and vice versa. The neural dust is interrogated by another component placed beneath the scale but powered from outside the body. This generates the ultrasound that powers the neural dust and sensors that listen out for their response, rather like an RFID system. The system is also tetherless - the data is collected and stored outside the body for later analysis. [Seo and co say] implanting the neural dust particles in the cortex ... can probably be done by fabricating the dust particles on the tips of a fine wire array, held in place by surface tension, for example. This array would be dipped into the cortex where the dust particles become embedded.

Note: For information on the risks and dangers of this invasive technology being used to control minds, see this article. For more along these lines, see concise summaries of deeply revealing news articles on microchip implants and mind control.

Physician influence can be bought for as little as a $20 meal, UCSF researchers have found. A study published Monday in JAMA Internal Medicine ... found that doctors who received just one meal averaging $20 were up to twice as likely to prescribe brand-name drugs being promoted than doctors who did not receive any free food. Gifts from pharmaceutical companies to doctors ... have come under scrutiny in recent years for concerns that the money spent by drugmakers directly influences what physicians write on their prescriptions pads. Some doctors deny they’re influenced by money, but a growing number of studies show that financial ties can affect their professional behavior. The UCSF researchers looked at ... the routine briefings many doctors and their staff receive from drug reps during lunches in their offices. The study found that the effect increased as doctors got more meals. Those who received multiple meals were up to three times as likely to prescribe the promoted brand-name drug. Higher-cost meals were associated with greater influence. Doctors who received four or more meals to promote Allergan’s Bystolic to treat hypertension prescribed the drug at 5.4 times the rate of physicians who received no meals. For Pfizer’s depression drug Pristiq, that rate was 3.4 times higher. UCSF researchers said that their studies show the buying power of drug makers decreases the use of cheaper, generic drugs and raises costs for patients as well as the health care system.

Note: For more along these lines, see concise summaries of deeply revealing big Pharma profiteering news articles from reliable major media sources.

The duty to guide patients through the end-of-life decision-making process rests squarely upon primary care providers, writes one internist in The New England Journal of Medicine. Susan Tolle, director of the Center for Ethics in Health Care at the Oregon Health and Science University, is one of three physicians responding to the NEJM’s most recent “Clinical Decisions” case feature, detailing a woman undergoing treatment for metastatic breast cancer. The two other physicians who responded with their opinions ... claim an oncologist or palliative specialist should initiate the conversation about the patient’s goals. But Tolle says it is the primary care physician’s obligation to lead this difficult discussion. [Yet] without widespread intervention of primary providers, patients will be less likely to ensure their end of life wishes are honored. Leaders within the American College of Physicians ... agree. “Somebody has to step up,” said Robert Centor, Chair of the ACP Board of Regents. “If you’re a primary care physician, it’s incumbent on you to have the discussion with patients before and especially after they get sick about goals. If we don’t know a patient’s goals, they can’t get the best possible care.” End of life planning, however, is not a billable Medicare service.

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Genentech and another drugmaker will pay $67 million to settle claims that they misled doctors into prescribing a treatment to lung cancer patients for whom the companies knew it would not work. As a result, some patients may have died earlier than they would have if they had taken more effective drugs, a lawsuit brought by a former Genentech employee and joined by federal prosecutors alleges. From 2006 to 2011 Genentech and its marketing partner OSI Pharmaceuticals promoted Tarceva to treat all patients with non-small-cell lung cancer even though studies had shown that it worked for just those who had never smoked or had a certain gene mutation known as EGFR. Epidermal growth factor receptor is a type of protein found on the surface of cells in the body. The whistle-blower lawsuit was filed in 2011 by Brian Shields, who worked as a Tarceva sales representative and then a product manager. The lawsuit said the companies ... discouraged doctors from testing patients for EGFR. The companies also promoted Tarceva ... by giving doctors illegal kickbacks disguised as fees for making speeches or serving on Genentech’s advisory boards. Sales representatives across the country were “instructed to spend lavishly” on physicians, the case said, and given “an unlimited budget to wine and dine.” Genentech also organized lunches or dinners for lung cancer patients where “patient ambassadors” were paid fees to speak about how Tarceva could be used in ways never approved by regulators, the lawsuit said.

Note: While Genentech was inaccurately describing its new drugs to doctors and patients, this company was also fiercely lobbying to prevent others from selling affordable alternatives to its costly drugs. Practices like this, along with the suppression of promising cancer research, show how Big Pharma puts profit before people.

A technique that allows particular genes to spread rapidly through populations is not ready to be set loose in the wild, warns a committee convened by the US National Academies of Sciences, Engineering, and Medicine. In a [new] report ... the committee argued that such ‘gene drives’ pose complex ecological risks that are not yet fully understood. “We are not ready for any kind of release,” says Elizabeth Heitman, co-chair of the committee. Gene drives ... have long been postulated as a way to eradicate mosquito-borne diseases such as malaria. But the field was hampered by technical challenges until the recent advent of sophisticated - and easy-to-use - tools for engineering genomes. In the past two years, researchers have used a popular gene-editing technique called CRISPR–Cas9 to develop gene drives that spread a given gene through a population almost exponentially faster than normal. But as molecular biology research on gene drives has surged forward, it has outpaced our understanding of their ecological consequences, says Heitman. Even a small, accidental release from a laboratory holds the potential to spread around the globe: “After release into the environment, a gene drive knows no political boundaries,” the committee wrote. Given this risk, the report also stressed the importance of layering multiple methods of containment to prevent accidental release of engineered species, and of consulting with the public even before gene drive experiments are undertaken in the laboratory.

Note: According to the Washington Post, the USDA recently stated that it will not regulate a food product product engineered with this risky CRISPR technique. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.